Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
Wilma Barcellini, Francesco Zaja, Anna Zaninoni, et al.
Blood (2012) Vol. 119, Iss. 16, pp. 3691-3697
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Ulrich Jäger, Wilma Barcellini, Catherine M. Broome, et al.
Blood Reviews (2019) Vol. 41, pp. 100648-100648
Open Access | Times Cited: 399
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
Wilma Barcellini, Bruno Fattizzo, Anna Zaninoni, et al.
Blood (2014) Vol. 124, Iss. 19, pp. 2930-2936
Open Access | Times Cited: 309
Treatment of autoimmune hemolytic anemias
Alberto Zanella, Wilma Barcellini
Haematologica (2014) Vol. 99, Iss. 10, pp. 1547-1554
Open Access | Times Cited: 243
The diagnosis and management of primary autoimmune haemolytic anaemia
Quentin A. Hill, R. Stamps, Edwin Massey, et al.
British Journal of Haematology (2016) Vol. 176, Iss. 3, pp. 395-411
Open Access | Times Cited: 215
How I treat autoimmune hemolytic anemia
Ronald S. Go, Jeffrey L. Winters, Neil E. Kay
Blood (2017) Vol. 129, Iss. 22, pp. 2971-2979
Open Access | Times Cited: 174
New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
Wilma Barcellini
Transfusion Medicine and Hemotherapy (2015) Vol. 42, Iss. 5, pp. 287-293
Open Access | Times Cited: 153
A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
Henrik Birgens, Henrik Frederiksen, Hans Carl Hasselbalch, et al.
British Journal of Haematology (2013) Vol. 163, Iss. 3, pp. 393-399
Open Access | Times Cited: 144
Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single‐center experience with 60 patients
Mathilde Roumier, Valentine Loustau, Constance Guillaud, et al.
American Journal of Hematology (2014) Vol. 89, Iss. 9
Open Access | Times Cited: 131
Diagnosis and classification of autoimmune hemolytic anemia
Garrett Bass, Emily Tuscano, Joseph M. Tuscano
Autoimmunity Reviews (2014) Vol. 13, Iss. 4-5, pp. 560-564
Closed Access | Times Cited: 123
Autoimmune cytopenias in chronic lymphocytic leukemia
Carlo Visco, Wilma Barcellini, Francesco Maura, et al.
American Journal of Hematology (2014) Vol. 89, Iss. 11, pp. 1055-1062
Open Access | Times Cited: 107
A randomized and double‐blind controlled trial evaluating the safety and efficacy of rituximab for warm auto‐immune hemolytic anemia in adults (the RAIHA study)
Marc Michel, Louis Terriou, Françoise Roudot‐Thoraval, et al.
American Journal of Hematology (2016) Vol. 92, Iss. 1, pp. 23-27
Open Access | Times Cited: 103
How I manage patients with cold agglutinin disease
Sigbjørn Berentsen
British Journal of Haematology (2018) Vol. 181, Iss. 3, pp. 320-330
Open Access | Times Cited: 98
Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment
Quentin A. Hill, Anita Hill, Sigbjørn Berentsen
Blood Advances (2019) Vol. 3, Iss. 12, pp. 1897-1906
Open Access | Times Cited: 98
How I treat warm autoimmune hemolytic anemia
Wilma Barcellini, Bruno Fattizzo
Blood (2021) Vol. 137, Iss. 10, pp. 1283-1294
Open Access | Times Cited: 92
Autoimmune hemolytic anemia: current knowledge and perspectives
Sylwia Sulimiera Michalak, Anna Olewicz‐Gawlik, Joanna Rupa‐Matysek, et al.
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 88
New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
Wilma Barcellini, Anna Zaninoni, Juri Alessandro Giannotta, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3859-3859
Open Access | Times Cited: 85
Plasma Cells in the Mucosa of Patients with Inflammatory Bowel Disease Produce Granzyme B and Possess Cytotoxic Activities
Maria Laura Cupi, Massimiliano Sarra, Irene Marafini, et al.
The Journal of Immunology (2014) Vol. 192, Iss. 12, pp. 6083-6091
Open Access | Times Cited: 78
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study
Giuseppe Rossi, Doriana Gramegna, Francesca Paoloni, et al.
Blood (2018) Vol. 132, Iss. 5, pp. 547-550
Open Access | Times Cited: 77
Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review
Abdulgabar Salama
Transfusion Medicine and Hemotherapy (2015) Vol. 42, Iss. 5, pp. 294-301
Open Access | Times Cited: 76
Autoimmune Hemolytic Anemia
Howard A. Liebman, Ilene C. Weitz
Medical Clinics of North America (2016) Vol. 101, Iss. 2, pp. 351-359
Closed Access | Times Cited: 75
The role of rituximab in adults with warm antibody autoimmune hemolytic anemia
Daan Dierickx, Alain Kentos, André Delannoy
Blood (2015) Vol. 125, Iss. 21, pp. 3223-3229
Open Access | Times Cited: 73
Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: a multicentre international study
Bruno Fattizzo, Marc Michel, Anna Zaninoni, et al.
Haematologica (2020) Vol. 106, Iss. 2, pp. 622-625
Open Access | Times Cited: 54
Molecular pharmacology in complement‐mediated hemolytic disorders
Marta Bortolotti, Wilma Barcellini, Bruno Fattizzo
European Journal Of Haematology (2023) Vol. 111, Iss. 3, pp. 326-336
Open Access | Times Cited: 18
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review
Marcella Visentini, Carmine Tinelli, Stefania Colantuono, et al.
Autoimmunity Reviews (2015) Vol. 14, Iss. 10, pp. 889-896
Open Access | Times Cited: 60
Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab
Matthieu Mahévas, Marc Michel, Benoît Vingert, et al.
Journal of Autoimmunity (2015) Vol. 62, pp. 22-30
Closed Access | Times Cited: 52
Page 1 - Next Page

Scroll to top